1. Centers for Disease Control and Prevention. Prevalence of Obesity Among Adults and Youth: United States, 2015–2016. Available at https://www.cdc.gov/nchs/products/databriefs/db288.htm. Last accessed May 7, 2024.

2. Centers for Disease Control and Prevention. Prevalence of Obesity and Severe Obesity Among Adults: United States, 2017–2018. Available at https://www.cdc.gov/nchs/products/databriefs/db360.htm. Last accessed May 7, 2024.

3. Flegal KM, Graubard BI, Williamson DF, Gail MH. Excess deaths associated with underweight, overweight, and obesity. JAMA. 2005;293(15):1861-1867.

4. Centers for Disease Control and Prevention. National Diabetes Prevention Program: Joint a Lifestyle Change Program. Available at https://www.cdc.gov/diabetes/prevention/people-at-risk.html. Last accessed May 7, 2024.

5. United States Food and Drug Administration. UPDATE: Potential Risks with Liquid-filled Intragastric Balloons, Letter to Health Care Providers. Available at https://public4.pagefreezer.com/content/FDA/08-08-2023T13:42/https://www.fda.gov/medical-devices/letters-health-care-providers/update-potential-risks-liquid-filled-intragastric-balloons-letter-health-care-providers. Last accessed May 7, 2024.

6. National Institutes of Health. Benefits of Moderate Weight Loss in People with Obesity. Available at https://www.nih.gov/news-events/nih-research-matters/benefits-moderate-weight-loss-people-obesity. Last accessed May 7, 2024.

7. Huang Z, Willett WC, Manson JE, et al. Body weight, weight change, and risk for hypertension in women. Ann Intern Med. 1998;128(2):81-88.

8. American Society for Metabolic and Bariatric Surgery. Metabolic and Bariatric Surgery. Available at https://asmbs.org/resources/metabolic-and-bariatric-surgery. Last accessed May 7, 2024.

9. Batsis JA, Sarr MG, Collazo-Clavell ML, et al. Cardiovascular risk after bariatric surgery for obesity. Am J Cardiol. 2008;102(7):930-937.

10. Brethauer SA, Chand B, Schauer PR. Risks and benefits of bariatric surgery: current evidence. Cleve Clin J Med. 2006;73(11):993-1007.

11. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity in the United States, 2009–2010. NCHS Data Brief. 2012;82:1-8.

12. Flegal KM, Kruszon-Moran D, Carroll MD, Fryar CD, Ogden CL. Trends in obesity among adults in the United States, 2005 to 2014. JAMA. 2016;315(21):2284-2291.

13. U. S. Department of Health and Human Services. Reduce the Proportion of Adults with Obesity—NWS-03. Available at https://health.gov/healthypeople/objectives-and-data/browse-objectives/overweight-and-obesity/reduce-proportion-adults-obesity-nws-03. Last accessed May 7, 2024.

14. Office of Disease Prevention and Health Promotion. Healthy People 2030: Nutrition and Weight Status Workgroup Objectives (17). Available at https://health.gov/healthypeople/about/workgroups/nutrition-and-weight-status-workgroup. Last accessed May 7, 2024.

15. Iachan R, Pierannunzi C, Healey K, Greenlund KJ, Town M. National weighting of data from the Behavioral Risk Factor Surveillance System (BRFSS). BMC Med Res Methodol. 2016;16:155.

16. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2020. Available at https://www.cdc.gov/diabetes/pdfs/data/statistics/national-diabetes-statistics-report.pdf. Last accessed May 7, 2024.

17. Centers for Disease Control and Prevention. Diabetes Data and Statistics. Available at https://www.cdc.gov/diabetes/data/. Last accessed May 7, 2024.

18. Centers for Disease Control and Prevention. National Diabetes Statistics Report. Available at https://www.cdc.gov/diabetes/data/statistics-report/index.html#. Last accessed May 7, 2024.

19. Zhao Y, Encinosa W. Statistical Brief 23: Bariatric Surgery Utilization and Outcomes in 1998 and 2004. Available at https://www.ncbi.nlm.nih.gov/books/NBK63485/pdf/Bookshelf_NBK63485.pdf. Last accessed May 7, 2024.

20. American Society for Metabolic and Bariatric Surgery. Estimate of Bariatric Surgery Numbers, 2011-2022. Available at https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers. Last accessed May 7, 2024.

21. Aly S, Hachey K, Pernar LIM. Gender disparities in weight loss surgery. Mini-Invasive Surg. 2020;4:21.

22. Young MT, Phelan MJ, Nguyen NT. A decade analysis of trends and outcomes of male vs. female patients who underwent bariatric surgery. J Am Coll Surg. 2016;222(3):226-231.

23. Kelleher DC, Merrill CT, Cottrell LT, Nadler EP, Burd RS. Recent national trends in the use of adolescent inpatient bariatric surgery: 2000 through 2009. JAMA Pediatr. 2013;167(2):126-132.

24. Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures – 2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Endocrine Pract. 2019;25(12):1-75.

25. Mechanick JI, Apovian C, Brethauer S, et al. Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of patients undergoing bariatric procedures—2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, The Obesity Society, American Society for Metabolic and Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists. Endocrine Practice. 2019;25(12):1-75.

26. Khorgami Z, Aminian A, Shoar S, et al. Cost of bariatric surgery and factors associated with increased cost: an analysis of national inpatient sample. Surg Obes Relat Dis. 2017;13(8):1284-1289.

27. Doble B, Wordsworth S, Rogers CA, et al. What are the real procedural costs of bariatric surgery? A systematic literature review of published cost analyses. Obes Surg. 2017;27(8):2179-2192.

28. Centers for Medicare and Medicaid Services. National Coverage Determination (NCD) for Bariatric Surgery for Treatment of Co-Morbid Conditions Related to Morbid Obesity. Available at https://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId=57&ncdver=5. Last accessed May 7, 2024.

29. Sherman D. Device Makers Urge Coverage of Weight-Loss Surgery. Available at https://www.reuters.com/article/us-healthcare-obesity/device-makers-urge-coverage-of-weight-loss-surgery-idUSTRE80N2GB20120124. Last accessed May 7, 2024.

30. Nguyen NT, Silver M, Robinson M, et al. Result of a national audit of bariatric surgery performed at academic centers: a 2004 University HealthSystem Consortium Benchmarking Project. Arch Surg. 2006;141(5):445-449.

31. Consensus Development Conference Panel. NIH conference: gastrointestinal surgery for severe obesity. Ann Intern Med. 1991;115(12):956-961.

32. Snow V, Barry P, Fitterman N, Qaseem A, Weiss K. Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2005;142(7):525-531.

33. Eisenberg D, Shikora SA, Aarts E, et al. 2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery. Obes Surg. 2023;33(1):3-14.

34. Edwards MA, Mazzei M, Agarwal S, Rhodes L, Bruff A. Exploring perioperative outcomes in metabolic and bariatric surgery amongst the elderly: an analysis of the 2015-2017 MBSAQIP database. Surg Obes Relat Dis. 2021;17(6):1096-1106.

35. American Society for Metabolic and Bariatric Surgery. Bariatric Surgery Guidelines and Recommendations. Available at https://asmbs.org/resources/bariatric-surgery-guidelines-and-recommendations. Last accessed May 7, 2024.

36. Sogg S, Lauretti J, West-Smith L. Recommendations for the presurgical psychosocial evaluation of bariatric surgery patients. Surg Obes Relat Dis. 2016;12(4):731-749.

37. Sugerman HJ. Effects of increased intra-abdominal pressure in severe obesity. Surg Clin North Am. 2001;81(5):1063-1075.

38. Lambert DM, Marceau S, Forse RA. Intra-abdominal pressure in the morbidly obese. Obes Surg. 2005;15(9):1225-1232.

39. Romy S, Donadini A, Giusti V, Suter M. Roux-en-Y gastric bypass vs gastric banding for morbid obesity: a case-matched study of 442 patients. Arch Surg. 2012;147(5):460-466.

40. Still CD, Benotti P, Wood GC, et al. Outcomes of preoperative weight loss in high-risk patients undergoing gastric bypass surgery.Arch Surg. 2007;142(10):994-998.

41. Alami RS, Morton JM, Schuster R, et al. Is there a benefit to preoperative weight loss in gastric bypass patients? A prospective randomized trial. Surg Obes Relat Dis. 2007;3(2):141-145.

42. Gibbons LM, Sarwer DB, Crerand CE, et al. Previous weight loss experiences of bariatric surgery candidates: how much have patients dieted prior to surgery? Obesity. 2006;14(Suppl 2):70S-76S.

43. Jamal MK, DeMaria EJ, Johnson JM, et al. Insurance-mandated preoperative dietary counseling does not improve outcome and increases dropout rates in patients considering gastric bypass surgery for morbid obesity. Surg Obes Relat Dis. 2006;2(2):122-127.

44. Colles SL, Dixon JB, Marks P, Strauss BJ, O'Brien PE. Preoperative weight loss with a very-low-energy diet: quantitation of changes in liver and abdominal fat by serial imaging. Am J Clin Nutr. 2006;84(2):304-311.

45. The American Society for Metabolic and Bariatric Surgery. ASMBS Updated Position Statement on Insurance Mandated Preoperative Supervised Weight Loss Requirements. Available at https://asmbs.org/resources/preoperative-supervised-weight-loss-requirements/. Last accessed May 7, 2024.

46. Kim JJ, Rogers AM, Ballem N, et al. ASMBS updated position statement on insurance mandated preoperative weight loss requirements. Surg Obes Relat Dis. 2016;12(5):955-959.

47. Gu L, Huang X, Li S, et al. A meta-analysis of the medium- and long-term effects of laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass. BMC Surg. 2020;20(30):1-10.

48. Neagoe R, Muresan M, Timofte D, et al. Long-term outcomes of laparoscopic sleeve gastrectomy: a single-center prospective observational study. Wideochir Inne Tech Maloinwazyjne. 2019;14(2):242-248.

49. Schouten R, Rijs CS, Bouvy ND, et al. A multicenter, randomized efficacy study of the EndoBarrier Gastrointestinal Liner for presurgical weight loss prior to bariatric surgery. Ann Surg. 2010;251(2):236-243.

50. Cohen R, Uzzan B, Bihan H, Khochtali I, Reach G, Catheline JM. Ghrelin levels and sleeve gastrectomy in super-super-obesity. Obes Surg. 2005;15(10):1501-1502.

51. Lautz D, Halperin F, Goebel-Fabbri A, Goldfine AB. The Great Debate: Medicine or Surgery. What is Best for the Patient With Type 2 Diabetes? Available at https://www.medscape.com/viewarticle/738769. Last accessed May 7, 2024.

52. Gagner M. Is sleeve gastrectomy always an absolute contraindication in patients with Barrett's? Obes Surg. 2016;26(4):715-717.

53. The American Society for Metabolic and Bariatric Surgery. Bariatric Surgery Procedures. Available at https://asmbs.org/patients/bariatric-surgery-procedures. Last accessed May 7, 2024.

54. American Society of Metabolic and Bariatric Surgery. Story of Obesity Surgery. Available at https://asmbs.org/resources/story-of-obesity-surgery. Last accessed May 7, 2024.

55. MedlinePlus. Gastric Bypass Surgery. Available at https://medlineplus.gov/ency/article/007199.htm. Last accessed May 7, 2024.

56. O'Brien P. Is weight loss more successful after gastric bypass than gastric banding for obese patients? Nat Clin Pract Gastroenterol Hepatol. 2009;6(3):136-137.

57. Dapri G, Cadiere GB, Himpens J. Laparoscopic reconversion of Roux-en-Y gastric bypass to original anatomy: technique and preliminary outcomes. Obes Surg. 2011;21(8):1289-1295.

58. Arman GA, Himpens J, Bolckmans R, et al. Medium-term outcomes after reversal of roux-en-Y gastric bypass. Obes Surg. 2018;28(3):781-790.

59. MedlinePlus. Laparoscopic Gastric Banding. Available at https://medlineplus.gov/ency/article/007388.htm. Last accessed May 7, 2024.

60. Allergan. LAP-BAND AP Adjustable Gastric Banding System with RapidPort EZ and OMNIFORM Design. Available at https://www.cms.gov/Medicare/Coverage/DeterminationProcess/Downloads/OkersonComment04252012.pdf. Last accessed May 7, 2024.

61. Fernandes M, Atallah AN, Soares BGO, et al. Intragastric balloon for obesity. Cochrane Database Syst Rev. 2007;1:CD004931.

62. Kumar N, Bazerbachi F, Rustagi T, et al. The influence of the Orbera intragastric balloon filling volumes on weight loss, tolerability, and meta-analysis. Obes Surg. 2017;27(9):2272-2278.

63. Genco A, Cipriano M, Bacci V, et al. BioEnterics Intragastric Balloon (BIB): a short-term, double-blind, randomised, controlled, corssover study on weight reduction in morbidly obese patients. Int J Obes. 2006;30(1):129-133.

64. U.S. Food and Drug Administration. [Archived Content]. UPDATE: Potential Risks With Liquid-Filled Intragastric Balloons – Letter to Health Care Providers. Available at https://public4.pagefreezer.com/browse/FDA/21-08-2022T08:51/https://www.fda.gov/medical-devices/letters-health-care-providers/update-potential-risks-liquid-filled-intragastric-balloons-letter-health-care-providers. Last accessed May 7, 2024.

65. Elder KA, Wolfe BM. Bariatric surgery: a review of procedures and outcomes. Gastroenterology. 2007;132(6):2253-2271.

66. U.S. Food and Drug Administration. Medical Devices for Weight Loss and Weight Management: What to Know. Available at https://www.fda.gov/consumers/consumer-updates/medical-devices-weight-loss-and-weight-management-what-know. Last accessed May 7, 2024.

67. U.S. Food and Drug Administration. FDA Approves AspireAssist Obesity Device. Available at https://www.fda.gov/newsevents/newsroom/pressannouncements/ucm506625.htm. Last accessed May 7, 2024.

68. NewsWise. The Academy for Eating Disorders Expresses Concern About the FDA Approval of a Mechanized Purging Device. Available at https://www.newswise.com/articles/the-academy-for-eating-disorders-expresses-concern-about-the-fda-approval-of-a-mechanized-purging-device. Last accessed May 7, 2024.

69. Harris B, Szoka N. TransPyloric Shuttle. Available at https://www.sages.org/publications/tavac/transpyloric-shuttle. Last accessed May 7, 2024.

70. Gelesis Granted FDA Clearance to Market PLENITY—a New Prescription Aid in Weight Management. Available at https://www.gelesis.com/2019/04/14/gelesis-granted-fda-clearance-to-market-plenitytm-a-new-prescription-aid-to-weight-management. Last accessed May 7, 2024.

71. Griffen WO Jr, Bivins BA, Bell RM. The decline and fall of the jejunoileal bypass. Surg Gynecol Obstet. 1983;157(4):301-308.

72. Van Hee RH. Biliopancreatic diversion in the surgical treatment of morbid obesity. World J Surg. 2004;28(5):435-444.

73. Brethauer SA, Chand B, Schauer PR, Thompson CC. Transoral gastric volume reduction as intervention for weight management: 12-month follow-up of TRIM trial. Surg Obes Relat Dis. 2012;8(3):296-303.

74. ClinicalTrials.gov. Transoral Gastric Volume Reduction as an Intervention for Weight Management (TRIM). Available at https://clinicaltrials.gov/ct2/show/NCT00679848. Last accessed May 7, 2024.

75. Brethauer SA, Chand B, Schauer PR, Thompson CC. Transoral gastric volume reduction for weight management: technique and feasibility in 18 patients. Surg Obes Related Dis. 2010;6(6):689-694.

76. Moreno C, Closset J, Dugardeyn S, et al. Transoral gastroplasty is safe, feasible, and induces significant weight loss in morbidly obese patients: results of the second human pilot study. Endoscopy. 2008;40(5):406-413.

77. Familiari P, Costamagna G, Bléro D, et al. Transoral gastroplasty for morbid obesity: a multicenter trial with a 1-year outcome. Gastrointest Endosc. 2011;74(6):1248-1258.

78. Mann D, Snyder BE. Transoral Gastroplasty (Toga). Available at http://www.yourbariatricsurgeryguide.com/transoral-gastroplasty. Last accessed May 7, 2024.

79. Winder JS, Rodriguez JH. Emerging endoscopic interventions in bariatric surgery. Surg Clin North Am. 2021;101(2):373-379.

80. Hadefi A, Arvanitakis M, Huberty V, Deviere J. Metabolic endoscopy: today's science – tomorrow's treatment. United European Gastroenterol J. 2020;8(6):685-694.

81. Dolan RD, Schulman AR. Endoscopic approaches to obesity management. Annu Rev Med. 2022;73:423-438.

82. Simons M, Sharaiha RZ. Updates in metabolic bariatric endoscopy. Dig Endosc. 2024;36(2):107-115.

83. Buchwald H, Estok R, Fahrbach K, Banel D, Sledge I. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery. 2007;142(4):621-635.

84. Ali M, El Chaar M, Ghiassi S, Rogers AM, American Society for Metabolic and Bariatric Surgery Clinical Issues Committee. American Society for Metabolic and Bariatric Surgery updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis. 2017;13(10):1652.

85. Nguyen NT, Paya M, Stevens CM, Mavandadi S, Zainabadi K, Wilson SE. The relationship between hospital volume and outcome in bariatric surgery at academic medical centers. Ann Surg. 2004;240(4):586-594.

86. Birkmeyer NJO, Dimick JB, Share D, et al. Hospital complication rates with bariatric surgery in Michigan. JAMA. 2010;304(4):435-442.

87. American Society for Metabolic and Bariatric Surgery. MBSAQIP . Available at https://asmbs.org/about/mbsaqip/. Last accessed May 7, 2024.

88. Inabnet W, Bour E, Joyce C, et al. Part 4: the American Society for Metabolic and Bariatric Surgery Bariatric Surgery Center of Excellence Bariatric Quality Improvement Program (ASMBS BSCOE/BQIP). Joint Task Force Recommendations for Credentialing of Bariatric Surgeons. Available at http://s3.amazonaws.com/publicASMBS/Items_of_Interest/Part-4-Credentialing.pdf. Last accessed May 7, 2024.

89. Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142(7):547-559.

90. Sarkhosh K, Birch DW, Sharma A, Karmali S. Complications associated with laparoscopic sleeve gastrectomy for morbid obesity: a surgeon's guide. Can J Surg. 2013;56(5):347-352.

91. Edwards ED, Jacob BP, Gagner M, Pomp A. Presentation and management of common post-weight loss surgery problems in the emergency department. Ann Emerg Med. 2006;47(2):160-166.

92. Ellsmere JC. Bariatric Operations: Late Complications with Subacute Presentations. Available at https://www.uptodate.com/contents/bariatric-operations-late-complications-with-subacute-presentations. Last accessed May 7, 2024.

93. Tucker ON, Fajnwaks P, Szomstein S, Rosenthal RJ. Is concomitant cholecystectomy necessary in obese patients undergoing laparoscopic gastric bypass surgery? Surg Endosc. 2008;22(11):2450-2454.

94. Virji A, Murr MM. Caring for patients after bariatric surgery. Am Fam Physician. 2006;73(8):1403-1408.

95. Karmon A, Sheiner E. Pregnancy after bariatric surgery: a comprehensive review. Arch Gynecol Obstet. 2008;277(5):381-388.

96. Hezelgrave NL, Oteng-Ntim E. Pregnancy after bariatric surgery: a review. J Obes. 2011;2011:501939.

97. Karmon A, Sheiner E. Timing of gestation after bariatric surgery: should women delay pregnancy for at least 1 perioperative year?Amer J Perinatol. 2008;25(6):331-333.

98. Armstrong C. ACOG guidelines on pregnancy after bariatric surgery. Am Fam Physician. 2010;81(7):905-906.

99. The American College of Obstetricians and Gynecologists. Committee Opinion 549: Obesity in Pregnancy, 2013. Available at http://www.sdb.unipd.it/sites/sdb.unipd.it/files/Obesity%20and%20Pregnancy%20Guide%20Line%20ACOG%202013.pdf. Last accessed May 7, 2024.

100. Angrisani L, Lorenzo M, Borrelli V. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 5-year results of a prospective randomized trial. Surg Obes Relat Dis. 2007;3(2):127-132.

101. Angrisani L, Cutolo PP, Formisano G, Nosso G, Vitolo G. Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 10-year results of a prospective, randomized trial. Surg Obes Dis. 2013;9(3):405-413.

102. Tice JA, Karliner L, Walsh J, Petersen AJ, Feldman MD. Gastric banding or bypass? A systematic review comparing the two most popular bariatric procedures. Am J Med. 2008;121(10):885-893.

103. Han Y, Jia Y, Wang H, Cao L, Zhao Y. Comparative analysis of weight loss and resolution of comorbidities between laparoscopic sleeve gastrectomy and Roux-en-Y gastric bypass: a systematic review and meta-analysis based on 18 studies. Int J Surg. 2020;76:101-110.

104. Franco JV, Ruiz PA, Palermo M, Gagner M. A review of studies comparing three laparoscopic procedures in bariatric surgery: sleeve gastrectomy, Roux-en-Y gastric bypass and adjustable gastric banding. Obes Surg. 2011;21(9):1458-1468.

105. Sjöström L. Review of the key results from the Swedish Obese Subjects (SOS) trial: a prospective controlled intervention study of bariatric surgery. J Intern Med. 2013;273(3):219-234.

106. Sjöström L. Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study. Int J Obes (Lond). 2008;32(Suppl 7):S93-S97.

107. Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg. 2004;240(3):416-424.

108. O'Brien PE, McPhail T, Chaston TB, Dixon JB. Systematic review of medium-term weight loss after bariatric operations. Obes Surg. 2006;16(8):1032-1040.

109. Hauser DL, Titchner RL, Wilson MA, Eid GM. Long-term outcomes of laparoscopic Roux-en-Y gastric bypass in U.S. veterans. Obes Surg. 2010;20(3):283-289.

110. Yan E, Ko E, Luong V, Wang HJ, Romanova M, Li Z. Long-term changes in weight loss and obesity-related comorbidities after Roux-en-Y gastric bypass: a primary care experience. Am J Surg. 2008;195(1):94-98.

111. McMahon MM, Sarr MG, Clark MM, et al. Clinical management after bariatric surgery: value of a multidisciplinary approach.Mayo Clin Proc. 2006;81(10 Suppl):S34-S45.

112. Hoyuela C. Five-year outcomes of laparoscopic sleeve gastrectomy as a primary procedure for morbid obesity: a prospective study.World J Gastrointest Surg. 2017;9(4):109-117.

113. Zera C, McGirr S, Oken E. Screening for obesity in reproductive-aged women. Prev Chronic Dis. 2011;8(6):A125.

114. Dalle Grave R, Calugi S, Molinari E, et al. Weight loss expectations in obese patients and treatment attrition: an observational multicenter study. Obes Res. 2005;13(11):1961-1969.

115. Dalle Grave R, Calugi S, Corica F, Di Domizio S, Marchesini G, QUOVADIS Study Group. Psychological variables associated with weight loss in obese patients seeking treatment at medical centers. J Am Diet Assoc. 2009;109(12):2010-2016.

116. Odom J, Zalesin KC, Washington TL, et al. Behavioral predictors of weight regain after bariatric surgery. Obes Surg. 2010;20(3):349-356.

117. Batsis JA, Lopez-Jimenez F, Collazo-Clavell ML, Clark MM, Somers VK, Sarr MG. Quality of life after bariatric surgery: a population-based cohort study. Am J Med. 2009;122(1):1055.e1-1055.e10.

118. Daskalakis M, Weiner RA. Sleeve gastrectomy as a single-stage bariatric operation: indications and limitations. Obes Facts. 2009;2(Suppl 1):8-10.

119. Salmela J, Konttinen H, Lappalainen R, et al. Eating behavior dimensions and 9-year weight loss maintenance: a sub-study of the Finnish Diabetes prevention study. Int J Obes (Lond). 2023;47(7):564-573.

120. Mechanick JI. Bariatric Surgery and the Role of the Clinical Endocrinologist. Available at https://www.medscape.com/viewarticle/752004. Last accessed May 7, 2024.

121. Blonde L, Umpierrez GE, Reddy SS, et al. American Association of Clinical Endocrinology clinical practice guideline: developing a diabetes mellitus comprehensive care plan – 2022 update. Endocrine Pract. 2022;28(10):923-1049.

122. Hinojosa MW, Varela JE, Smith BR, Che F, Nguyen NT. Resolution of systemic hypertension after laparoscopic gastric bypass.J Gastrointest Surg. 2009;13(4):793-797.

123. Look AHEAD Research Group. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care. 2007;30(6):1374-1383.

124. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299(3):316-323.

125. Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. JAMA. 2012;308:1122-1131.

126. Riddle MC, Cefalu WT, Evans PH, et al. Consensus report: definition and interpretation of remission in type 2 diabetes. Diabetes Care. 2021;44(10):2438-2444.

127. Moradi M, Kabir A, Khalili D, et al. Type 2 diabetes remission after Roux-en-Y gastric bypass (RYBG), sleeve gastrectomy (SG), and one anastomosis gastric bypass (OAGB): results of the longitudinal assessment of bariatric study. BMC Endocrine Disord. 2022;22:260.

128. Hofsø D, Fatima F, Borgeraas H, et al. Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes: a single-centre, triple-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 2019;7(12):912-924.

129. Courcoulas AP, Gallagher JW, Neiberg RH, et al. Bariatric surgery vs lifestyle intervention for diabetes treatment: 5-year outcomes from a randomized trial. J Clin Endocrinol Metab. 2020;105:866-876.

130. Mingrone G, Panunzi S, De Gaetano A, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up or an open-label, single-centre, randomised controlled trial. Lancet. 2021;397(10271):293-304.

131. Courcoulas AP, Patti ME, Hu B, et al. Long-term outcomes of medical management vs bariatric surgery in type 2 diabetes. JAMA. 2024;331(8):654-664.

132. Guidone C, Manco M, Valera-Mora E, et al. Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery. Diabetes. 2006;55(7):2025-2031.

133. Pories WJ, Albrecht RJ. Etiology of type II diabetes mellitus: role of the foregut. World J Surg. 2001;25(4):527-531.

134. Finelli C, Padula MC, Martelli G, Tarantino G. Could the improvement of obesity-related comorbidities depend on modified gut hormones secretion? World J Gastroenterol. 2014;20(44):16649-16664.

135. Zhu J, Gupta R, Safwa M. The mechanism of metabolic surgery: gastric center hypothesis. Obes Surg. 2016;26:1639-1641.

136. Steven S, Hollingsworth KG, Small PK, et al. Calorie restriction and not glucagon-like peptide-1 explains the acute improvement in glucose control after gastric bypass in type 2 diabetes. Diabet Med. 2016;33:1723-1731.

137. Schernthaner G, Morton JM. Bariatric surgery in patients with morbid obesity and type 2 diabetes. Diabetes Care. 2008;31(Suppl 2):S297-S302.

138. Korner J, Inabnet W, Conwell IM, et al. Differential effects of gastric bypass and banding on circulating gut hormones and leptin levels. Obesity. 2006;14(9):1553-1561.

139. White S, Brooks E, Jurikova L, Stubbs RS. Long-term outcomes after gastric bypass. Obes Surg. 2005;15(2):155-163.

140. Jamal M, Wegner R, Heitshusen D, Liao J, Samuel I. Resolution of hyperlipidemia follows surgical weight loss in patients undergoing Roux-en-Y gastric bypass surgery: a 6-year analysis of data. Surg Obes Relat Dis. 2011;7(4):473-479.

141. Ahmed AR, Rickards G, Coniglio D, et al. Laparoscopic Roux-en-Y gastric bypass and its early effects on blood pressure. Obes Surg. 2009;19(7):845-849.

142. Benaiges D, Sagué M, Flores-Le Roux JA, et al. Predictors of hypertension remission and recurrence after bariatric surgery. Am J Hypertens. 2016;29(5):653-659.

143. Ebadinejad A, Shahshahani M, Hosseinpanah F, et al. Comparison of hypertension remission and relapse after sleeve gastrectomy and one-anastomosis gastric bypass: a prospective cohort study. Hypertens Res. 2023;46(5):1287-1296.

144. Williams DB, Hagedorn JC, Lawson EH, et al. Gastric bypass reduces biochemical cardiac risk factors. Surg Obes Relat Dis. 2007;3(1):8-13.

145. Busetto L, Sergi G, Enzi G, et al. Short-term effects of weight loss on the cardiovascular risk factors in morbidly obese patients. Obes Res. 2004;12(8):1256-1263.

146. Dixon JB, O'Brien PE. Health outcomes of severely obese type 2 diabetic subjects 1 year after laparoscopic adjustable gastric banding. Diabetes Care. 2002;25(2):358-363.

147. Peluso L, Vanek VW. Efficacy of gastric bypass in the treatment of obesity-related comorbidities. Nutr Clin Pract. 2007;22(1):22-28.

148. Sears D, Fillmore G, Bui M, Rodriguez J. Evaluation of gastric bypass patients 1 year after surgery: changes in quality of life and obesity-related conditions. Obes Surg. 2008;18(12):1522-1525.

149. Brolin RE, Bradley LJ, Wilson AC, Cody RP. Lipid risk profile and weight stability after gastric restrictive operations for morbid obesity. J Gastrointest Surg. 2000;4(5):464-469.

150. Heber D, Greenway FL, Kaplan LM, et al. Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95(11):4823-4843.

151. Spivak H, Sakran N, Dicker D, et al. Different effects of bariatric surgical procedures on dyslipidemia: a registry-based analysis. Surg Obes Relat Dis. 2017;13(7):1189-1194.

152. Adil MT, Perera M, Whitelaw D, et al. Systematic review and meta-analysis of the effects of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy on dyslipidemia. Obes Surg. 2024;34(3):967-975.

153. Gasteyger C, Suter M, Calmes JM, Gaillard RC, Giusti V. Changes in body composition, metabolic profile and nutritional status 24 months after gastric banding. Obes Surg. 2006;16(3):243-250.

154. Giusti V, Suter M, Heraäef E, Gaillard RC, Burckhardt P. Effects of laparoscopic gastric banding on body composition, metabolic profile and nutritional status of obese women: 12 months follow-up. Obes Surg. 2004;14(2):239-245.

155. Arterburn D, Schauer DP, Wise RE, et al. Change in predicted 10-year cardiovascular risk following laparoscopic Roux-en-Y gastric bypass surgery. Obes Surg. 2009;19(2):184-189.

156. Vogel JA, Franklin BA, Zalesin KC, et al. Reduction in predicted coronary heart disease risk after substantial weight reduction after bariatric surgery. Am J Cardiol. 2007;99(2):222-226.

157. Kligman MD, Dexter DJ, Omer S, Park AE. Shrinking cardiovascular risk through bariatric surgery: application of Framingham risk score in gastric bypass. Surgery. 2008;143(4):533-538.

158. Torquati A, Wright K, Melvin W, Richards W. Effect of gastric bypass operation on Framingham and actual risk of cardiovascular events in class II to III obesity. J Am Coll Surg. 2007;204(5):776-782.

159. Lizer MH, Papageorgeon H, Glembot TM. Nutritional and pharmacologic challenges in the bariatric surgery patient. Obes Surg. 2010;20(12):1654-1659.

160. Benotti PN, Wood GC, Carey DJ. Gastric bypass surgery produces a durable reduction in cardiovascular disease risk factors and reduces the long-term risks of congestive heart failure. J Am Heart Assoc. 2017;6:e005126.

161. Aminian A, Wilson R, Al-Kurd A, et al. Association of bariatric surgery with cancer risk and mortality in adults with obesity. JAMA. 2022;327(24):2423-2433.

162. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741-752.

163. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753-761.

164. Heneghan HM, Meron-Eldar S, Brethauer SA, Schauer PR, Young JB. Effect of bariatric surgery on cardiovascular risk profile. Am J Cardiol. 2011;108(10):1499-1507.

165. Marinella MA. Anemia following Roux-en-Y surgery for morbid obesity: a review. South Med J. 2008;101(10):1024-1031.

166. Ben-Porat T, Elazary R, Godenshluger A, et al. Nutritional deficiencies four years after laparoscopic sleeve gastrectomy: are supplements required for a lifetime? Surg Obes Reat Dis. 2017;13(7):1138-1144.

167. Parrott J, Frank L, Rabena R, Craggs-Dino L, et al. ASMBS integrated health nutritional guidelines for the surgical weight loss patient: 2016 update: micronutrients. Surg Obes Relat Dis. 2017;13(5):727-741.

168. Decker GA, Swain JM, Crowell MD, Scolapio JS. Gastrointestinal and nutritional complications after bariatric surgery. Am J Gastroenterol. 2007;102(11):2571-2580.

169. Miller AD, Smith KM. Medication and nutrient administration considerations after bariatric surgery. Am J Health-Syst Pharm. 2006;63(19):1852-1857.

170. Alvarado R, Alami RS, Hsu G, et al. The impact of preoperative weight loss in patients undergoing laparoscopic Roux-en-Y gastric bypass. Obes Surg. 2005;15(9):1282-1286.

171. Ibrahim T, Ansari WE, Abusabeib A, Yousaf Z, Elhag W. Infrequent but serious? Beriberi and thiamine deficiency among adolescents and young adults after bariatric surgery. Surg Obes Relat Dis. 2024;2092):115-126.

172. Angstadt JD, Bodziner RA. Peripheral polyneuropathy from thiamine deficiency following laparoscopic Roux-en-Y gastric bypass.Obes Surg. 2005;15(6):890-892.

173. Alves LF, Gonçalves RM, Cordeiro GV, Lauria MW, Ramos AV. Beriberi after bariatric surgery: not an unusual complication: report of two cases and literature review. Arq Bras Endocrinol Metabol. 2006;50(3):564-568.

174. Nelson ML, Bolduc LM, Toder ME, Clough DM, Sullivan SS. Correction of preoperative vitamin D deficiency after Roux-en-Y gastric bypass surgery. Surg Obes Relat Dis. 2007;3(4):434-437.

175. Mahlay NF, Verka LG, Thomsen K, Merugu S, Salomone M. Vitamin D status before Roux-en-Y and efficacy of prophylactic and therapeutic doses of vitamin D in patients after Roux-en-Y gastric bypass surgery. Obes Surg. 2009;19(5):590-594.

176. Goldner WS, Stoner JA, Lyden E, et al. Finding the optimal dose of vitamin D following Roux-en-Y gastric bypass: a prospective, randomized pilot clinical trial. Obes Surg. 2009;19(2):173-179.

177. Fleischer J, Stein EM, Bessler M, et al. The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss. J Clin Endocrinol Metab. 2008;93(10):3735-3740.

178. Shai I, Henkin Y, Weitzman S, Levi I. Long-term dietary changes after vertical banded gastroplasty: is the trade-off favorable? Obes Surg. 2002;12(6):805-811.

179. Breitman I, Saraf N, Kakade M, et al. The effects of an amino acid supplement on glucose homeostatis, inflammatory markers, and incretins after laparoscopic gastric bypass. J Am Coll Surg. 2011;212(4):617-625.

180. Angeles PC, Robertsen I, Seeberg LT, et al. The influence of bariatric surgery on oral drug bioavailability in patients with obesity: a systematic review. Obes Rev. 2019;20(9):1299-1311.

181. Smith A, Henriksen B, Cohen A. Pharmacokinetic Considerations in Roux-en-Y Gastric Bypass Patients. Available at https://www.medscape.com/viewarticle/754391. Last accessed May 7, 2024.

182. Potoczna N, Harfmann S, Steffen R, Briggs R, Bieri N, Horber FF. Bowel habits after bariatric surgery. Obes Surg. 2008;18(10):1287-1296.

183. Elias K, Bekhali Z, Hedberg J, Graf W, Sundbom M. Changes in bowel habits and patient-scored symptoms after Roux-en-Y gastric bypass and biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis. 2018;14(2):144-149.

184. U.S. Preventive Services Task Force. Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions. Available at https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/obesity-in-adults-interventions. Last accessed May 7, 2024.

185. U.S. Department of Health and Human Services. Physical Activity Guidelines for Americans: 2nd edition. Available at https://health.gov/sites/default/files/2019-09/Physical_Activity_Guidelines_2nd_edition.pdf. Last accessed May 7, 2024.

186. American Heart Association. American Heart Association Recommendations for Physical Activity in Adults and Kids. Available at https://www.heart.org/en/healthy-living/fitness/fitness-basics/aha-recs-for-physical-activity-in-adults. Last accessed May 7, 2024.

187. Fenske W, Parker J, Bloom SR. Pharmacotherapy for Obesity. Available at https://www.medscape.com/viewarticle/746807. Last accessed May 7, 2024.

188. LexiComp Online. Available at https://online.lexi.com. Last accessed May 7, 2024.

189. U.S. Food and Drug Administration. FDA Approves Weight-Management Drug Saxenda. Available at https://wayback.archive-it.org/7993/20170111160832/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427913.htm. Last accessed May 7, 2024.

190. U.S. Food and Drug Administration. FDA Approves New Medication for Chronic Weight Management. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-new-medication-chronic-weight-management. Last accessed May 7, 2024.

191. Norris SL, Zhang X, Avenell A, Gregg E, Schmid CH, Lau J. Pharmacotherapy for weight loss in adults with type 2 diabetes mellitus. Cochrane Database Syst Rev. 2005;1:CD004096.

192. Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005;142(7):532-546.

193. Lee M, Aronne LJ. Weight management for type 2 diabetes mellitus: global cardiovascular risk reduction. Am J Cardiol. 2007;99(4A):68B-79B.

194. U.S. Food and Drug Administration. Press Release: FDA Approves Weight-Management Drug Qsymia. Available at https://web.archive.org/web/20160303175603/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm312468.htm. Last accessed May 7, 2024.

195. U.S. Food and Drug Administration. FDA Briefing Document: NDA 22529 Lorcaserin Hydrochloride Tablets. Available at http://www.diabetesincontrol.com/wp-content/uploads/2012/05/www.fda.gov_downloads_AdvisoryCommittees_CommitteesMeetingMaterials_Drugs_EndocrinologicandMetabolicDrugsAdvisoryCommittee_UCM303198.pdf. Last accessed May 7, 2024.

196. U.S. Food and Drug Administration. FDA Approves Weight-Management Drug Contrave. Available at https://wayback.archive-it.org/7993/20170112222826/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm413896.htm. Last accessed May 7, 2024.

197. Halpern B, Faria AM, Halpern A. Bupropion/naltrexone fixed-dose combination for the treatment of obesity. Drugs Today (Barc). 2011;47(8):575-581.

198. U.S. Food and Drug Administration. FDA Approves New Drug Treatment for Chronic Weight Management, First Since 2014. Available at https://www.fda.gov/news-events/press-announcements/fda-approves-new-drug-treatment-chronic-weight-management-first-2014. Last accessed May 7, 2024.

199. Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384:989-1002.

200. Wadden TA, Berkowitz RI, Womble LG, et al. Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med. 2005;353(20):2111-2120.